Shikari® (S-ATCAN) Anti-Canakinumab ELISA w/confirmation

Enzyme immunoassay for the quantitative determination of antibodies to Canakinumab (Ilaris®) in human serum and plasma.

This kit has been especially developed for the quantitative determination of canakinumab in serum and plasma samples.

The Matriks Biotek Antibody to Canakinumab ELISA Kit can be efficiently used for monitoring anti-Canakinumab antibodies during therapy and offers the clinician a tool for decision on possible preventive measures such as possible addition of immunosuppressive drug to reduce anti-Canakinumab antibodies. Measurement of biological drug trough levels and antibody to biological drug gained high importance during the course of treatment. These measurements enable dose adjustments and switch to another class of biological drug when necessary.

All SHIKARI® ELISA kits are suitable for biosimilar work.